Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...

Keyera released both its fourth-quarter and full-year 2024 results. After digesting the news, we maintain our CAD 41 fair value estimate.

Enbridge (ENB) is a Strong Buy due to favorable market conditions, robust growth projects, and a solid 6% forward dividend yield.